Scientists Explore 10,000 Compounds for an Ebola Drug
Dr. Baek Kim, faculty member in MSP and MMG, and Dr. Raymond Schinazi, faculty member in MMG, were recently highlighted in Time Magazine for their work in developing an Ebola treatment. Emory Hospital's infectious disease team has already treated four patients with Ebola, and now a team of biochemists known for their work on HIV are working to develop a treatment for Ebola.
The team, led by Dr. Kim, is fast-tracking a program to screen a library of over 10,000 chemical compounds that can treat viruses at the molecular level to see if one or more of them may show promise with Ebola.
“We need to start screening many, many compounds,” says Kim. Anywhere from 500 to 10,000 compounds will be screened—each of which will be evaluated one by one.
Dr. Schinazi, who discovered compounds used in multiple very successful anti-HIV drugs, will be working with five to 10 virologists, chemists and biochemists to get the job done.
Dr. Kim is Director of the Emory's Children's Scientists at Emory’s Children’s Center for Drug Discovery. His team has extensively studied the development of drugs for HIV that stop the replication of the virus in the body. The center provided breakthroughs for HIV drug development and, more recently, the development of a drug for Hepatitis C.
Click here to read the full article on Time.com.